| Characterizing exposure–response relationship for therapeutic monoclonal antibodies in immuno‐oncology and beyond: challenges, perspectives, and prospects HI Dai, Y Vugmeyster, N Mangal Clinical Pharmacology & Therapeutics 108 (6), 1156-1170, 2020 | 53 | 2020 |
| Impact of the CYP2C19 genotype on voriconazole exposure in adults with invasive fungal infections IS Hamadeh, KP Klinker, SJ Borgert, AI Richards, W Li, N Mangal, ... Pharmacogenetics and genomics 27 (5), 190-196, 2017 | 51 | 2017 |
| Optimization of voriconazole therapy for the treatment of invasive fungal infections in adults N Mangal, IS Hamadeh, MJ Arwood, LH Cavallari, TS Samant, KP Klinker, ... Clinical Pharmacology & Therapeutics 104 (5), 957-965, 2018 | 50 | 2018 |
| Quantitative clinical pharmacology for size and age scaling in pediatric drug development: a systematic review TS Samant, N Mangal, V Lukacova, S Schmidt The Journal of Clinical Pharmacology 55 (11), 1207-1217, 2015 | 43 | 2015 |
| Response rates as predictors of overall survival: a meta-analysis of acute myeloid leukemia trials SK Agarwal, N Mangal, RM Menon, KJ Freise, AH Salem Journal of Cancer 8 (9), 1562, 2017 | 26 | 2017 |
| Relationship between response rates and median progression‐free survival in non‐Hodgkin's lymphoma: a meta‐analysis of published clinical trials N Mangal, AH Salem, M Li, R Menon, KJ Freise Hematological oncology 36 (1), 37-43, 2018 | 23 | 2018 |
| Use of depth of response to predict progression‐free survival in relapsed or refractory multiple myeloma: Evaluation of results from 102 clinical trials N Mangal, AH Salem, RM Menon, KJ Freise Hematological Oncology 36 (3), 547-553, 2018 | 16 | 2018 |
| Model informed dose optimization of dichloroacetate for the treatment of congenital lactic acidosis in children N Mangal, MO James, PW Stacpoole, S Schmidt The Journal of Clinical Pharmacology 58 (2), 212-220, 2018 | 15 | 2018 |
| Clinical trials in oncology: a comprehensive review S Singla, D Sahai, N Mangal EC Pharmacology & Toxicology 8 (2), 1-11, 2020 | 2 | 2020 |
| Relationship between short-term response rates and long-term survival in acute myeloid leukemia and relapsed or refractory multiple myeloma N Mangal, AH Salem, R Menon, KJ Freise Blood 128 (22), 5128, 2016 | 2 | 2016 |
| Quantitative understanding of the longitudinal relationship between short-term MRI outcomes and long-term clinical outcomes measures in multiple sclerosis M Wiens, AH Maghzi, N Mangal, KK Muralidharan, H Naik, J French, ... MULTIPLE SCLEROSIS JOURNAL 27 (2_ SUPPL), 738-739, 2021 | 1 | 2021 |
| Modeling and simulation comparison of pharmacokinetics and pharmacodynamics of natalizumab every 6 weeks following subcutaneous and intravenous dosing Y Zhao, N Campbell, Z Ren, L Jin, S Levin, N Mangal, H Naik MULTIPLE SCLEROSIS JOURNAL 27 (1_ SUPPL), 25-25, 2021 | 1 | 2021 |
| Therapeutic applications of transdermal microneedles SK Singla, A Muthuraman, D Sahai, N Mangal, J Dhamodharan Frontiers in Bioscience-Elite 13 (1), 158-184, 2020 | 1 | 2020 |
| Exploring the impact of CYP2D6 and UGT2B7 gene-drug interactions, and CYP-mediated DDI on oxycodone and oxymorphone pharmacokinetics using physiologically-based pharmacokinetic … M Klose, R Cristofoletti, C de Miranda Silva, N Mangal, J Turgeon, ... European Journal of Pharmaceutical Sciences 194, 106689, 2024 | | 2024 |
| PREDICTING THE IMPACT OF CYP2D6/UGT2B7GENE-DRUG AND CYP MEDIATED DRUG-DRUG INTERACTIONS ON OXYCODONE AND OXYMORPHONE PHARMACOKINETICS. C Silva, D Miranda, N Mangal, V Michaud, J Turgeon, LJ Lesko, ... CLINICAL PHARMACOLOGY & THERAPEUTICS 103, S14-S14, 2018 | | 2018 |
| Development of a Physiologically Based Pharmacokinetic-Population Pharmacodynamic model for Oxycodone CM Silva, V Vozmediano Esteban, Y Nakatani, N Mangal, S Basu, ... JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS 44, S112-S113, 2017 | | 2017 |
| RELATIONSHIP BETWEEN RESPONSE RATES AND PROGRESSION-FREE SURVIVAL IN NON-HODGKIN'S LYMPHOMA N Mangal, AH Salem, M Li, R Menon, KJ Freise CLINICAL PHARMACOLOGY & THERAPEUTICS 101 (S 1), S38-S39, 2017 | | 2017 |
| HOW QUANTITATIVE CLINICAL PHARMACOLOGY CAN BRING VALUE TO THE PATIENT N MANGAL UNIVERSITY OF FLORIDA, 2017 | | 2017 |
| Model guided dose optimization of dichloroacetate for the treatment of congenital lactic acidosis N Mangal, AL Shroads, T Langaee, PW Stacpoole, S Schmidt DRUG METABOLISM REVIEWS 48, 134-134, 2016 | | 2016 |
| Editor’s Choice: Pediatric Pharmacology TS Samant, N Mangal, V Lukacova, S Schmidt, JR Avasarala, X Wang, ... | | 2015 |
